Magnetar Financial LLC Purchases 441,265 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Magnetar Financial LLC raised its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 2,350,598 shares of the company's stock after acquiring an additional 441,265 shares during the period. Option Care Health comprises 1.3% of Magnetar Financial LLC's portfolio, making the stock its 23rd biggest position. Magnetar Financial LLC owned about 1.38% of Option Care Health worth $54,534,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of OPCH. Westfield Capital Management Co. LP increased its position in shares of Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after acquiring an additional 599,589 shares during the last quarter. Global Alpha Capital Management Ltd. increased its position in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock worth $1,559,000 after purchasing an additional 25,905 shares during the last quarter. Graypoint LLC bought a new stake in shares of Option Care Health during the 4th quarter worth approximately $1,161,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Option Care Health in the 4th quarter valued at approximately $327,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price for the company. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $33.00.

Option Care Health Stock Performance

Option Care Health stock traded up $0.13 during midday trading on Monday, hitting $34.71. The company's stock had a trading volume of 1,794,594 shares, compared to its average volume of 1,640,421. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market cap of $5.74 billion, a price-to-earnings ratio of 29.17, a PEG ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.12. The company has a 50-day moving average price of $31.84 and a two-hundred day moving average price of $28.29.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.